Abstract:Cyclin-dependent kinase 5 (CDK5) in adipose tissue mediates peroxisome proliferator-activated receptor gamma (PPAR gamma) phosphorylation at Ser273 to inhibit its activity, causing PPAR gamma target gene expression changes. Among these, insulin-degrading enzyme (IDE) degrades amyloid-beta peptide (A beta), the core pathological product of Alzheimer's disease (AD), whereas beta-amyloid cleavage enzyme 1 (BACE1) hydrolyzes amyloid-beta protein precursor (A beta PP). Therefore, we speculated that CDK5 activity in the brain might participate in A beta production, thereby functioning as a key molecule in AD pathogenesis. To confirm this hypothesis, we transduced primary rat hippocampal neurons using CDK5-expressing lentiviral vectors. CDK5 overexpression increased PPAR gamma Ser273 phosphorylation, decreased IDE expression, increased BACE1 and A beta PP expression, increased A beta levels, and induced neuronal apoptosis. The CDK5 inhibitor roscovitine effectively reversed these CDK5 overexpression-mediated effects. Moreover, silencing of the Cdk5 gene via CDK5 shRNA-expressing lentiviral vectors in primary hippocampal neurons did not exert any protective effect against normal neuronal apoptosis, nor were significant effects observed on A beta levels, PPAR gamma phosphorylation, or PPAR gamma target gene expression in the cells. However, Cdk5 gene silencing exhibited a neuroprotective effect in the A beta-induced AD neuron model by effectively inhibiting the A beta-induced neuronal apoptosis, PPAR gamma phosphorylation, PPAR gamma expression downregulation, and PPAR gamma target gene expression changes, and reducing A beta levels. In conclusion, this study demonstrated that CDK5 played an important role in the pathogenesis of AD. Specifically, CDK5 participated in A beta production by regulating PPAR gamma phosphorylation. Targeted therapy against CDK5 could effectively reduce and reverse the neurotoxic effects of A beta and may represent a novel approach for AD treatment.

Wnt5a Promotes Cortical Neuron Survival by Inhibiting Cell-Cycle Activation.

WNT5A Signaling Contributes to Aβ-induced Neuroinflammation and Neurotoxicity.

Wnt-5a Prevents A Beta-Induced Deficits In Long-Term Potentiation And Spatial Memory In Rats

Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.

P3‐309: Overexpression of Hyperphosphorylated Tau Antagonizes Aβ‐potentiated Apoptosis with Preservation of Mitochondrial Elements

Protein Kinase C-Delta Mediates Cell Cycle Reentry and Apoptosis Induced by Amyloid-Beta Peptide in Post-Mitotic Cortical Neurons

P1‐285: Nucleocytoplasmic Cdk5 Links Cell Cycle and Cell Death in Post‐mitotic Neurons in Alzheimer's Disease

Astrocytic AT1R deficiency ameliorates Aβ-induced cognitive deficits and synaptotoxicity through β-arrestin2 signaling

The protein arginine methyltransferase PRMT5 regulates Aβ-induced toxicity in human cells and Caenorhabditis elegans models of Alzheimer's disease

Caspase-8 Mediates Amyloid-β-induced Apoptosis in Differentiated PC12 Cells

Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease

Changes In Mitochondrial Dynamics During Amyloid Beta-Induced Pc12 Cell Apoptosis

Overexpression Of Tau Proteins Antagonizes Amyloid-Beta-Potentiated Apoptosis Through Mitochondria-Caspase-3 Pathway In N2a Cells

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.

Protecting Synapses from Amyloid Β-Associated Degeneration by Manipulations of Wnt/planar Cell Polarity Signaling

The Role of Wnt Signaling in the Development of Alzheimer’s Disease: A Potential Therapeutic Target?

p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.

The Role of Cdk5 in Alzheimer’s Disease

Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.

The Protective Effects of Tanshinone IIA on Neurotoxicity Induced by Β-Amyloid Protein Through Calpain and the P35/cdk5 Pathway in Primary Cortical Neurons.